Trial to Evaluate the Immunogenicity of Dose Reduction Strategies of the MVA-BN Monkeypox Vaccine
Clinical trial NCT05512949 · COMPLETED
Trial details
- NCT number
- NCT05512949
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-09
- Primary completion
- 2023-10-12
- Enrollment
- 229
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.